Please provide your email address to receive an email when new articles are posted on . This is the first study to investigate treosulfan pharmacogenetics in a large uniform cohort of patients with ...

Credit: Shutterstock. Researchers sought to determine whether luspatercept would improve outcomes in patients with nontransfusion-dependent β-thalassemia. The following article features coverage from ...

beta-thalassemia minor, which causes few or no symptoms beta-thalassemia major, which causes serious symptoms and may require blood transfusions beta-thalassemia intermedia, which causes symptoms ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine A new chapter is unfolding for patients with sickle cell ...

People with the thalassemia trait, or thalassemia carriers, may not experience any symptoms. However, some thalassemia carriers can experience anemia symptoms, such as paleness and fatigue. In people ...

AAPI Nexus: Asian Americans and Pacific Islanders, Policy, Practice and Community, Vol. 4, No. 2, Youth (Summer/Fall 2006), pp. 111-134 (24 pages) Thalassemia is a potentially life-threatening genetic ...

Starting iron chelation therapy early may prevent growth problems and organ damage from iron overload in children with TDT. Currently approved medications have limitations for use in very young ...

Thalassemia is a common genetic condition affecting red blood cells. Children with severe forms of thalassemia often develop symptoms early in life, but effective treatment can manage the condition.

Thalassemia, a preventable genetic blood disorder, is not merely a medical condition; it is a demographic and social challenge that quietly but relentlessly impacts families, health systems, and ...

A balanced diet full of fruits and vegetables is often recommended for those with thalassemia minor. You may choose to eat this way even if you don’t have thalassemia-related anemia. Share on ...

The US Food and Drug Administration's (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the ...